speb/financial-data huggingface dataset:
CXI.TO balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 79446877.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 75980274.00
CXI.TO income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -111545.20
CXI.TO income_statement (quarterly, 2025-01-31) — Tax Provision: 1143591.00
CXI.TO income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.40
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Assets: 123115193.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 79446877.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Debt: 12721680.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 79446877.00
CXI.TO income_statement (quarterly, 2025-01-31) — Total Expenses: 12036508.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 43668316.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 13182180.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 7370250.00
CXI.TO income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 3823006.00
CXI.TO income_statement (quarterly, 2025-01-31) — Total Other Finance Cost: 184147.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Total Tax Payable: 597114.00
CXI.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items: -278863.00
CXI.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -278863.00
CXI.TO balance_sheet (quarterly, 2025-01-31) — Working Capital: 73634947.00
CXI.TO income_statement (quarterly, 2025-04-30) — +Operating Expense: 4993932.00
CXI.TO income_statement (quarterly, 2025-04-30) — +Total Revenue: 15865150.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 16957140.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 7506685.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -3604733.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 29748588.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Assets Held For Sale Current: 34169128.00
CXI.TO income_statement (quarterly, 2025-04-30) — Basic Average Shares: 6262156.00
CXI.TO income_statement (quarterly, 2025-04-30) — Basic EPS: 0.32
CXI.TO cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 92889765.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Buildings And Improvements: 6568663.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -360301.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 6978993.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Capital Stock: 6304762.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 73928005.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 73928005.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Cash Financial: 73928005.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -1995303.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -168679.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 9888205.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Account Payable: 4668991.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: -1423947.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: 4471174.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Payable: 4668991.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 4668991.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Receivables: -1608762.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 6107456.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -1608762.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Changes In Cash: 7724223.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Common Stock: 6304762.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 81153115.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -671011.00
CXI.TO income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 7235763.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 3842273.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Assets: 118090004.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 1787958.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 1787958.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 654691.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 654691.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 43129411.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Depreciation: 872407.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 872407.00
CXI.TO income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 872407.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 872407.00
CXI.TO income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 872407.00
CXI.TO income_statement (quarterly, 2025-04-30) — Depreciation Income Statement: 872407.00
CXI.TO income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 6396517.00
CXI.TO income_statement (quarterly, 2025-04-30) — Diluted EPS: 0.31
CXI.TO income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 1983025.00
CXI.TO income_statement (quarterly, 2025-04-30) — EBIT: 4029403.00
CXI.TO income_statement (quarterly, 2025-04-30) — EBITDA: 4901810.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: 909713.00
CXI.TO cash_flow (quarterly, 2025-04-30) — End Cash Position: 101523701.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -1995303.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 9527904.00
CXI.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Ppe: -5855.00
CXI.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 779212.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: -6477708.00
CXI.TO income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 2864600.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Goodwill: 1309701.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 3567828.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Gross PPE: 12390788.00
CXI.TO income_statement (quarterly, 2025-04-30) — Gross Profit: 8629387.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Hedging Assets Current: 440242.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 0.00
CXI.TO income_statement (quarterly, 2025-04-30) — Insurance And Claims: 175767.00
CXI.TO income_statement (quarterly, 2025-04-30) — Interest Expense: 129238.00
CXI.TO income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 129238.00
CXI.TO income_statement (quarterly, 2025-04-30) — Interest Income: 9555.00
CXI.TO income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 9555.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Interest Paid Supplemental Data: 28887.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Invested Capital: 81153115.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -168679.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Leases: 3257945.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 5191035.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 5191035.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -576328.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 2564180.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -671011.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income: 1983025.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 1983025.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 2674849.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income Discontinuous Operations: -691824.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 1983025.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 2674849.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 1983025.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 1983025.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Intangibles Purchase And Sale: -257887.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Interest Income: -279243.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -977846.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -977846.00
CXI.TO income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -279243.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: 100376.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Net PPE: 8786055.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -102414.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Net Short Term Debt Issuance: -401518.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 77585287.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Assets: 373138.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Assets: 373138.00
CXI.TO income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 4352002.00
CXI.TO income_statement (quarterly, 2025-04-30) — Normalized Income: 2297774.34
CXI.TO cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 9888205.00
CXI.TO income_statement (quarterly, 2025-04-30) — Operating Income: 3635455.00
CXI.TO income_statement (quarterly, 2025-04-30) — Operating Revenue: 15865150.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 6304762.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 1184421.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Current Liabilities: 19887349.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: -6477708.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Equity Interest: 3599108.00
CXI.TO income_statement (quarterly, 2025-04-30) — Other Gand A: 2091736.00
CXI.TO income_statement (quarterly, 2025-04-30) — Other Income Expense: 543953.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Intangible Assets: 2258127.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 149295.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 182347.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 1525811.00
CXI.TO income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: -5855.00
CXI.TO income_statement (quarterly, 2025-04-30) — Other Operating Expenses: 845966.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Payables: 16957140.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 20799413.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 861523.00
CXI.TO income_statement (quarterly, 2025-04-30) — Pretax Income: 3900165.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: -39092.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Purchase Of Intangibles: -257887.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -102414.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Receivables: 7506685.00
CXI.TO income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 7235763.00
CXI.TO income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 872407.00
CXI.TO income_statement (quarterly, 2025-04-30) — Rent And Landing Fees: 434940.00
CXI.TO income_statement (quarterly, 2025-04-30) — Rent Expense Supplemental: 434940.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: -576328.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -671011.00
CXI.TO income_statement (quarterly, 2025-04-30) — Restructuring And Mergern Acquisition: 229404.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 47978365.00
CXI.TO income_statement (quarterly, 2025-04-30) — Salaries And Wages: 162157.00
CXI.TO income_statement (quarterly, 2025-04-30) — Selling And Marketing Expense: 410959.00
CXI.TO income_statement (quarterly, 2025-04-30) — Selling General And Administration: 3275559.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Share Issued: 6304762.00
CXI.TO income_statement (quarterly, 2025-04-30) — Special Income Charges: -229404.00
CXI.TO cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 162157.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 81153115.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 77585287.00
CXI.TO income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 172733.34
CXI.TO income_statement (quarterly, 2025-04-30) — Tax Provision: 1225316.00
CXI.TO income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.31
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Assets: 130999372.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 81153115.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Debt: 6978993.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 81153115.00
CXI.TO income_statement (quarterly, 2025-04-30) — Total Expenses: 12229695.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 49846257.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 12909368.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 6716846.00
CXI.TO income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 5127514.00
CXI.TO income_statement (quarterly, 2025-04-30) — Total Other Finance Cost: 159560.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 0.00
CXI.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items: 549808.00
CXI.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 549808.00
CXI.TO balance_sheet (quarterly, 2025-04-30) — Working Capital: 74960593.00
CXI.TO income_statement (quarterly, 2025-07-31) — +Operating Expense: 5965424.00
CXI.TO income_statement (quarterly, 2025-07-31) — +Total Revenue: 21282968.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 28575353.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 12229997.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -3832155.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 28309893.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Allowance For Doubtful Accounts Receivable: 0.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Assets Held For Sale Current: 15685485.00
CXI.TO income_statement (quarterly, 2025-07-31) — Basic Average Shares: 6197425.00
CXI.TO income_statement (quarterly, 2025-07-31) — Basic EPS: 0.68
CXI.TO cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 101523701.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Buildings And Improvements: 6120653.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -385883.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 6559585.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Capital Stock: 6206366.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 90181344.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 90181344.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Cash Financial: 90181344.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -6681792.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -577505.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 8910036.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 5827833.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: 1246632.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: 374001.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Payable: 5827833.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 5827833.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Receivables: -2493267.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Change In Working Capital: 4955199.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: -2493267.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Changes In Cash: 1650739.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Common Stock: 6206366.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 83838660.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -1617608.00
CXI.TO income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 7615885.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 3898085.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Assets: 120003845.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 1788183.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 1788183.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 597776.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 597776.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 42437974.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Depreciation: 893860.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 893860.00
CXI.TO income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 893860.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 893860.00
CXI.TO income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 893860.00
CXI.TO income_statement (quarterly, 2025-07-31) — Depreciation Income Statement: 893860.00
CXI.TO income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 6304923.00
CXI.TO income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.67
CXI.TO income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 4245120.00
CXI.TO income_statement (quarterly, 2025-07-31) — EBIT: 7252103.00
CXI.TO income_statement (quarterly, 2025-07-31) — EBITDA: 8145963.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Effect Of Exchange Rate Changes: -159125.00
CXI.TO cash_flow (quarterly, 2025-07-31) — End Cash Position: 103015315.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -6681792.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 8524153.00
CXI.TO income_statement (quarterly, 2025-07-31) — Gain On Sale Of Ppe: 0.00
CXI.TO income_statement (quarterly, 2025-07-31) — Gain On Sale Of Security: -223121.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: -6496894.00
CXI.TO income_statement (quarterly, 2025-07-31) — General And Administrative Expense: 3550769.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Goodwill: 1309701.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 3635850.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Gross Accounts Receivable: 12229997.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Gross PPE: 12091217.00
CXI.TO income_statement (quarterly, 2025-07-31) — Gross Profit: 13667083.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Hedging Assets Current: 610078.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Income Tax Paid Supplemental Data: 230904.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Income Tax Payable: 1654001.00
CXI.TO income_statement (quarterly, 2025-07-31) — Insurance And Claims: 215581.00
CXI.TO income_statement (quarterly, 2025-07-31) — Interest Expense: 154128.00
CXI.TO income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 154128.00
CXI.TO income_statement (quarterly, 2025-07-31) — Interest Income: 10786.00
CXI.TO income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 10786.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Interest Paid Supplemental Data: 930285.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Invested Capital: 83838660.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -577505.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Leases: 3346439.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 4771402.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 4771402.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -693065.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Machinery Furniture Equipment: 2624125.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -1617608.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income: 4245120.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 4245120.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 5274418.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income Discontinuous Operations: -1029298.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 4245120.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 5274418.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 4245119.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 4245120.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Intangibles Purchase And Sale: -237443.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Interest Income: -352450.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: -5678271.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: -693065.00
CXI.TO income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -352450.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: 608976.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Net PPE: 8259062.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -148440.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Net Short Term Debt Issuance: -4985206.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 80202810.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Assets: 545985.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Assets: 545985.00
CXI.TO income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 8397197.00
CXI.TO income_statement (quarterly, 2025-07-31) — Normalized Income: 5461106.90
CXI.TO cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 8910036.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: -356197.00
CXI.TO income_statement (quarterly, 2025-07-31) — Operating Income: 7701659.00
CXI.TO income_statement (quarterly, 2025-07-31) — Operating Revenue: 21282968.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 6206366.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 637076.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Current Liabilities: 5924576.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: -6496894.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Equity Interest: 3595811.00
CXI.TO income_statement (quarterly, 2025-07-31) — Other Gand A: 2722237.00
CXI.TO income_statement (quarterly, 2025-07-31) — Other Income Expense: -251234.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Intangible Assets: 2326149.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: -365242.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 182350.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 1579056.00
CXI.TO income_statement (quarterly, 2025-07-31) — Other Operating Expenses: 1081205.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Payables: 30229354.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 34127439.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Prepaid Assets: 659865.00
CXI.TO income_statement (quarterly, 2025-07-31) — Pretax Income: 7097975.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Proceeds From Stock Option Exercised: 5111.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Properties: 0.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Purchase Of Intangibles: -237443.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -148440.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Receivables: 12229997.00
CXI.TO income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 7615885.00
CXI.TO income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 893860.00
CXI.TO income_statement (quarterly, 2025-07-31) — Rent And Landing Fees: 467644.00
CXI.TO income_statement (quarterly, 2025-07-31) — Rent Expense Supplemental: 467644.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -693065.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -1617608.00
CXI.TO income_statement (quarterly, 2025-07-31) — Restructuring And Mergern Acquisition: 28113.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 52223484.00
CXI.TO income_statement (quarterly, 2025-07-31) — Salaries And Wages: 145307.00
CXI.TO income_statement (quarterly, 2025-07-31) — Selling And Marketing Expense: 439590.00
CXI.TO income_statement (quarterly, 2025-07-31) — Selling General And Administration: 3990359.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Share Issued: 6206366.00
CXI.TO income_statement (quarterly, 2025-07-31) — Special Income Charges: -28113.00
CXI.TO cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 145307.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 83838660.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 80202810.00
CXI.TO income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -64545.10
CXI.TO income_statement (quarterly, 2025-07-31) — Tax Provision: 1823557.00
CXI.TO income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.26
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Assets: 132627092.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 83838660.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Debt: 6559585.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 83838660.00
CXI.TO income_statement (quarterly, 2025-07-31) — Total Expenses: 13581309.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 48788432.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 12623247.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 6350458.00
CXI.TO income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 8163290.00
CXI.TO income_statement (quarterly, 2025-07-31) — Total Other Finance Cost: 209108.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 1654001.00
CXI.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items: -251234.00
CXI.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -251234.00
CXI.TO balance_sheet (quarterly, 2025-07-31) — Working Capital: 77565871.00
CXI.TO income_statement (annual, 2025-10-31) — +Operating Expense: 22411591.00
CXI.TO income_statement (quarterly, 2025-10-31) — +Operating Expense: 6487179.00
CXI.TO income_statement (annual, 2025-10-31) — +Total Revenue: 72448097.00
CXI.TO income_statement (quarterly, 2025-10-31) — +Total Revenue: 19849119.00
CXI.TO balance_sheet (annual, 2025-10-31) — Accounts Payable: 21148274.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 21148274.00
CXI.TO balance_sheet (annual, 2025-10-31) — Accounts Receivable: 3387120.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 3387120.00
CXI.TO balance_sheet (annual, 2025-10-31) — Accumulated Depreciation: -3585331.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -3585331.00
CXI.TO balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 26138920.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 26138920.00
CXI.TO cash_flow (annual, 2025-10-31) — Asset Impairment Charge: 270122.00
CXI.TO balance_sheet (annual, 2025-10-31) — Assets Held For Sale Current: 7438712.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Assets Held For Sale Current: 7438712.00
CXI.TO income_statement (annual, 2025-10-31) — Basic Average Shares: 6058545.00
CXI.TO income_statement (annual, 2025-10-31) — Basic EPS: 1.70
CXI.TO cash_flow (annual, 2025-10-31) — Beginning Cash Position: 101877263.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 103015315.00
CXI.TO balance_sheet (annual, 2025-10-31) — Buildings And Improvements: 5396040.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Buildings And Improvements: 5396040.00
CXI.TO cash_flow (annual, 2025-10-31) — Capital Expenditure: -1486674.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -324862.00
CXI.TO balance_sheet (annual, 2025-10-31) — Capital Lease Obligations: 5894020.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 5894020.00
CXI.TO balance_sheet (annual, 2025-10-31) — Capital Stock: 6135120.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Capital Stock: 6135120.00
CXI.TO balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 95503795.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 95503795.00
CXI.TO balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 95503795.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 95503795.00
CXI.TO balance_sheet (annual, 2025-10-31) — Cash Financial: 95503795.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Cash Financial: 95503795.00
CXI.TO cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Financing Activities: -12710317.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -3301243.00
CXI.TO cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Investing Activities: -1486674.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -324862.00
CXI.TO cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Operating Activities: 15413409.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 3603267.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Account Payable: -8724909.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -11108926.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Other Current Assets: -564904.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: 247992.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Other Working Capital: 3235272.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: 510385.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Payable: -8724909.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Payable: -11108926.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Payables And Accrued Expense: -8724909.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -11108926.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Receivables: 7588291.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Receivables: 9155672.00
CXI.TO cash_flow (annual, 2025-10-31) — Change In Working Capital: 1533750.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -1194877.00
CXI.TO cash_flow (annual, 2025-10-31) — Changes In Account Receivables: 7588291.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: 9155672.00
CXI.TO cash_flow (annual, 2025-10-31) — Changes In Cash: 1216418.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Changes In Cash: -22838.00
CXI.TO balance_sheet (annual, 2025-10-31) — Common Stock: 6135120.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Common Stock: 6135120.00
CXI.TO balance_sheet (annual, 2025-10-31) — Common Stock Equity: 84698643.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 84698643.00
CXI.TO cash_flow (annual, 2025-10-31) — Common Stock Payments: -4759137.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Common Stock Payments: -1908084.00
CXI.TO income_statement (annual, 2025-10-31) — Cost Of Revenue: 28837700.00
CXI.TO income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 6914599.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Accrued Expenses: 4719224.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 4719224.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Assets: 108894371.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Assets: 108894371.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Capital Lease Obligation: 1574780.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 1574780.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Debt And Capital Lease Obligation: 1574780.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 1574780.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Deferred Liabilities: 384136.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 384136.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Deferred Revenue: 384136.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 384136.00
CXI.TO balance_sheet (annual, 2025-10-31) — Current Liabilities: 30497488.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 30497488.00
CXI.TO cash_flow (annual, 2025-10-31) — Depreciation: 3550693.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Depreciation: 912763.00
CXI.TO cash_flow (annual, 2025-10-31) — Depreciation Amortization Depletion: 3550693.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 912763.00
CXI.TO income_statement (annual, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 3550693.00
CXI.TO income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 912763.00
CXI.TO cash_flow (annual, 2025-10-31) — Depreciation And Amortization: 3550693.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 912763.00
CXI.TO income_statement (annual, 2025-10-31) — Depreciation And Amortization In Income Statement: 3550693.00
CXI.TO income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 912763.00
CXI.TO income_statement (annual, 2025-10-31) — Depreciation Income Statement: 3550693.00
CXI.TO income_statement (quarterly, 2025-10-31) — Depreciation Income Statement: 912763.00
CXI.TO income_statement (annual, 2025-10-31) — Diluted Average Shares: 6115158.00
CXI.TO income_statement (annual, 2025-10-31) — Diluted EPS: 1.69
CXI.TO income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 10318794.00
CXI.TO income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 3278120.00
CXI.TO income_statement (annual, 2025-10-31) — EBIT: 19727690.00
CXI.TO income_statement (quarterly, 2025-10-31) — EBIT: 5464098.00
CXI.TO income_statement (annual, 2025-10-31) — EBITDA: 23278383.00
CXI.TO income_statement (quarterly, 2025-10-31) — EBITDA: 6376861.00
CXI.TO cash_flow (annual, 2025-10-31) — Effect Of Exchange Rate Changes: -157398.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Effect Of Exchange Rate Changes: -56194.00
CXI.TO cash_flow (annual, 2025-10-31) — End Cash Position: 102936283.00
CXI.TO cash_flow (quarterly, 2025-10-31) — End Cash Position: 102936283.00
CXI.TO cash_flow (annual, 2025-10-31) — Financing Cash Flow: -12710317.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -3301243.00
CXI.TO cash_flow (annual, 2025-10-31) — Free Cash Flow: 13926735.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 3278405.00
CXI.TO income_statement (annual, 2025-10-31) — Gain On Sale Of Ppe: 50058.00
CXI.TO income_statement (quarterly, 2025-10-31) — Gain On Sale Of Ppe: 55913.00
CXI.TO income_statement (annual, 2025-10-31) — Gain On Sale Of Security: 353900.00
CXI.TO income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 76672.00
CXI.TO balance_sheet (annual, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -6560297.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -6560297.00
CXI.TO income_statement (annual, 2025-10-31) — General And Administrative Expense: 13092514.00
CXI.TO income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 3865767.00
CXI.TO balance_sheet (annual, 2025-10-31) — Goodwill: 1309701.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Goodwill: 1309701.00
CXI.TO balance_sheet (annual, 2025-10-31) — Goodwill And Other Intangible Assets: 3659671.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 3659671.00
CXI.TO balance_sheet (annual, 2025-10-31) — Gross PPE: 10802160.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Gross PPE: 10802160.00
CXI.TO income_statement (annual, 2025-10-31) — Gross Profit: 43610397.00
CXI.TO income_statement (quarterly, 2025-10-31) — Gross Profit: 12934520.00
CXI.TO balance_sheet (annual, 2025-10-31) — Hedging Assets Current: 280989.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Hedging Assets Current: 280989.00
CXI.TO cash_flow (annual, 2025-10-31) — Income Tax Paid Supplemental Data: 5036596.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Income Tax Paid Supplemental Data: 3044794.00
CXI.TO balance_sheet (annual, 2025-10-31) — Income Tax Payable: 65776.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 65776.00
CXI.TO income_statement (annual, 2025-10-31) — Insurance And Claims: 898860.00
CXI.TO income_statement (quarterly, 2025-10-31) — Insurance And Claims: 250381.00
CXI.TO income_statement (annual, 2025-10-31) — Interest Expense: 572903.00
CXI.TO income_statement (quarterly, 2025-10-31) — Interest Expense: 145713.00
CXI.TO income_statement (annual, 2025-10-31) — Interest Expense Non Operating: 572903.00
CXI.TO income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 145713.00
CXI.TO income_statement (annual, 2025-10-31) — Interest Income: 183754.00
CXI.TO income_statement (quarterly, 2025-10-31) — Interest Income: 132669.00
CXI.TO income_statement (annual, 2025-10-31) — Interest Income Non Operating: 183754.00
CXI.TO income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 132669.00
CXI.TO cash_flow (annual, 2025-10-31) — Interest Paid Supplemental Data: 1195634.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Interest Paid Supplemental Data: 180101.00
CXI.TO balance_sheet (annual, 2025-10-31) — Invested Capital: 84698643.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 84698643.00
CXI.TO cash_flow (annual, 2025-10-31) — Investing Cash Flow: -1486674.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -324862.00
CXI.TO balance_sheet (annual, 2025-10-31) — Leases: 2762620.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Leases: 2762620.00
CXI.TO balance_sheet (annual, 2025-10-31) — Long Term Capital Lease Obligation: 4319240.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 4319240.00
CXI.TO balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 4319240.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 4319240.00
CXI.TO cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -2369030.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -535557.00
CXI.TO balance_sheet (annual, 2025-10-31) — Machinery Furniture Equipment: 2643500.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 2643500.00
CXI.TO cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: -4759137.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: -1908084.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income: 10318794.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income: 3278120.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 10318794.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 3278120.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 14026889.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 4382952.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income Discontinuous Operations: -3708095.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income Discontinuous Operations: -1104832.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 10318794.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 3278120.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 14026889.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 4382952.00
CXI.TO cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 10318794.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 3278120.00
CXI.TO income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 10318794.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 3278120.00
CXI.TO cash_flow (annual, 2025-10-31) — Net Intangibles Purchase And Sale: -914053.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net Intangibles Purchase And Sale: -235225.00
CXI.TO income_statement (annual, 2025-10-31) — Net Interest Income: -1562302.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Interest Income: -633383.00
CXI.TO cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -7369136.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: -550457.00
CXI.TO cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: -2369030.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -535557.00
CXI.TO income_statement (annual, 2025-10-31) — Net Non Operating Interest Income Expense: -1562302.00
CXI.TO income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -633383.00
CXI.TO balance_sheet (annual, 2025-10-31) — Net PPE: 7216829.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Net PPE: 7216829.00
CXI.TO cash_flow (annual, 2025-10-31) — Net PPE Purchase And Sale: -572621.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -89637.00
CXI.TO cash_flow (annual, 2025-10-31) — Net Short Term Debt Issuance: -5000106.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Net Short Term Debt Issuance: -14900.00
CXI.TO balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 81038972.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 81038972.00
CXI.TO balance_sheet (annual, 2025-10-31) — Non Current Deferred Assets: 1027197.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Assets: 1027197.00
CXI.TO balance_sheet (annual, 2025-10-31) — Non Current Deferred Taxes Assets: 1027197.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Assets: 1027197.00
CXI.TO income_statement (annual, 2025-10-31) — Normalized EBITDA: 23849780.00
CXI.TO income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 6962114.00
CXI.TO income_statement (annual, 2025-10-31) — Normalized Income: 14445318.20
CXI.TO income_statement (quarterly, 2025-10-31) — Normalized Income: 4865266.80
CXI.TO cash_flow (annual, 2025-10-31) — Operating Cash Flow: 15413409.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 3603267.00
CXI.TO cash_flow (annual, 2025-10-31) — Operating Gains Losses: 22842.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: 373184.00
CXI.TO income_statement (annual, 2025-10-31) — Operating Income: 21198806.00
CXI.TO income_statement (quarterly, 2025-10-31) — Operating Income: 6447341.00
CXI.TO income_statement (annual, 2025-10-31) — Operating Revenue: 72448097.00
CXI.TO income_statement (quarterly, 2025-10-31) — Operating Revenue: 19849119.00
CXI.TO balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 6135120.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 6135120.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Current Assets: 876516.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 876516.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Current Liabilities: 2605298.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 2605298.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Equity Adjustments: -6560297.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -6560297.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Equity Interest: 3483296.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Interest: 3483296.00
CXI.TO income_statement (annual, 2025-10-31) — Other Gand A: 9615413.00
CXI.TO income_statement (quarterly, 2025-10-31) — Other Gand A: 2628012.00
CXI.TO income_statement (annual, 2025-10-31) — Other Income Expense: -481717.00
CXI.TO income_statement (quarterly, 2025-10-31) — Other Income Expense: -495573.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Intangible Assets: 2349970.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 2349970.00
CXI.TO cash_flow (annual, 2025-10-31) — Other Non Cash Items: -1052265.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -572256.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Non Current Assets: 182347.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 182347.00
CXI.TO balance_sheet (annual, 2025-10-31) — Other Non Current Liabilities: 1465044.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 1465044.00
CXI.TO income_statement (annual, 2025-10-31) — Other Non Operating Income Expenses: 89680.00
CXI.TO income_statement (annual, 2025-10-31) — Other Operating Expenses: 4138997.00
CXI.TO income_statement (quarterly, 2025-10-31) — Other Operating Expenses: 1244990.00
CXI.TO income_statement (annual, 2025-10-31) — Other Special Charges: 291075.00
CXI.TO balance_sheet (annual, 2025-10-31) — Payables: 21214050.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Payables: 21214050.00
CXI.TO balance_sheet (annual, 2025-10-31) — Payables And Accrued Expenses: 25933274.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 25933274.00
CXI.TO balance_sheet (annual, 2025-10-31) — Prepaid Assets: 1407239.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 1407239.00
CXI.TO income_statement (annual, 2025-10-31) — Pretax Income: 19154787.00
CXI.TO income_statement (quarterly, 2025-10-31) — Pretax Income: 5318385.00
CXI.TO cash_flow (annual, 2025-10-31) — Proceeds From Stock Option Exercised: -582044.00
CXI.TO cash_flow (quarterly, 2025-10-31) — Proceeds From Stock Option Exercised: -541080.00
CXI.TO balance_sheet (annual, 2025-10-31) — Properties: 0.00
CXI.TO balance_sheet (quarterly, 2025-10-31) — Properties: 0.00
CXI.TO cash_flow (annual, 2025-10-31) — Purchase Of Intangibles: -914053.00